Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28450558.
- Also identified by DOI 10.2967/jnumed.116.182873 and PMC identifier 5450364.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, <sup>18</sup>F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment.
Medical subject headings
- Atherosclerosis
- Molecular Imaging
- Positron-Emission Tomography
- Venous Thromboembolism